Onconova Therapeutics, Inc. Appoints Richard Woodman as Chief Medical Officer and Senior Vice President of Research & Development
November 07, 2018 at 08:30 am EST
Onconova Therapeutics, Inc. announced the appointment of Dr. Richard “Ric” Woodman as Chief Medical Officer and Senior Vice President of Research & Development. Dr. Woodman will report to Dr. Steve Fruchtman, President and former CMO of the company. Ric Woodman, M.D., served most recently as Senior Vice President and Head of U.S. Oncology Clinical Development and Medical Affairs for Novartis. In his role, Ric provided strategic medical and scientific leadership for both marketed and development-stage compounds.